Monitoring the health of newborns in intensive care
Official title: Monitoring Key Activity and Physiology of Neonates in Intensive Care
Run by Cambridge University Hospitals NHS Foundation Trust · NCT04831242 · Data updated 2026-11-12
This study is testing a new non-contact monitoring system to see if it can help improve the care of newborns in intensive care who are at risk for seizures.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | Cambridge University Hospitals NHS Foundation Trust Academic / other |
| Locations | 1 site (Cambridge) |
| Status | Recruiting |
| Started | August 1, 2021 |
| Main results expected | December 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | April 18, 2025 |
| Trial ID | NCT04831242 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are neonates admitted to the NICU who require close monitoring due to potential health risks.
✕Probably not a fit
Patients who are not in the NICU or do not require intensive monitoring may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to optimize and evaluate a new non-contact physiological monitoring system designed for use in the neonatal intensive care unit (NICU). By continuously monitoring key activities and physiological parameters of neonates, the study seeks to improve the care and outcomes for infants at risk of neonatal seizures. The observational approach will involve collecting data on the effectiveness and reliability of this monitoring system in a real-world clinical setting.
Why it matters
Potential benefit: If successful, this study could enhance the safety and monitoring of neonates, potentially leading to better outcomes for infants with neonatal seizures.
How similar studies have gone: While this approach is innovative, similar non-contact monitoring systems have shown promise in other settings, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * written informed parental consent Exclusion Criteria: \-
Where it's running
-
Addenbrookes Hospital
Cambridge, United Kingdom Recruiting
Study contacts
- Study coordinator: kathryn beardsall
- Email: kb274@cam.ac.uk
- Phone: 01223 746791
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing Levetiracetam for treating neonatal seizures
This study is testing how much of the medication Levetiracetam is safe to give to newborns with seizures to see if it works better than the standard treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.